# US 2026/0063649 A1 · Process for determining pregnancy and/or a pregnancy stage of an ungulate from its feces

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0063649 A1
- Document ID: US20260063649A1
- Status: Published application
- Kind: A1
- Application number: 18/819,075
- Filed: 2024-08-29
- Published: 2026-03-05
- Earliest claimed: 2024-08-29
- Applicants: Université de Liège; Centre Hospitalier Universitaire de Liège
- Inventors: Jérôme PONTHIER; Etienne CAVALIER; Vincent FRISÉE; Patrice DUFOUR; Caroline LE GOFF
- Web page: https://patentgrep.com/patent/US20260063649A1

## CPC

- G01N 33/743: {Steroid hormones}
- G01N 2800/36: Gynecology or obstetrics
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a process for determining pregnancy and/or a pregnancy stage of an ungulate from its feces.

## Claims

### Claim 1

A process for determining pregnancy and/or a pregnancy stage of an ungulate from its feces, comprising:
an extraction of steroids from an ungulate's feces sample previously taken or collected to obtain an extract comprising steroids,
a dosage of estrone-sulfate steroid (E1S) present in the extract by a separative method coupled to mass spectrometry to determine an estrone-sulfate steroid (E1S) concentration in the extract,
a determination of the pregnancy and/or of the pregnancy stage of the ungulate based on the estrone-sulfate steroid (E1S) concentration with reference to a predetermined threshold value estrone-sulfate steroid (E1S) concentration above which the ungulate is determined as being pregnant.

### Claim 2 (depends on 1)

A process according to claim 1 wherein the ungulate's feces sample is stored at a temperature inferior to 15° C., preferably at a temperature inferior to 10° C., within 6 hours of taking or collecting the sample before the extraction of steroids from the feces sample.

### Claim 3 (depends on 1)

A process according to claim 1 wherein the ungulate's feces sample is frozen at a temperature inferior to 0° C., preferably at a temperature inferior to −10° C., more preferably at a temperature ranging from −20° C. to −80° C., even more preferably at a temperature of −80° C., within 6 hours of taking or collecting the sample before the extraction of steroids from the feces sample.

### Claim 4 (depends on 1)

A process according to claim 1 wherein the extraction of steroids from the ungulate's feces sample is performed with an organic solvent, for example with methanol.

### Claim 5 (depends on 1)

A process according to claim 1 wherein the extract comprising steroids is washed with a washing solution, for example with hexane.

### Claim 6 (depends on 1)

A process according to claim 1 wherein the separative method is a chromatographic method, for example gas chromatography or liquid chromatography or high-performance liquid chromatography or thin layer chromatography.

### Claim 7 (depends on 1)

A process according to claim 1 wherein the predetermined threshold value estrone-sulfate steroid (E1S) concentration ranges from 10 pg/g to 500 pg/g.

### Claim 8 (depends on 1)

A process according to claim 1 wherein testosterone as an additional steroid is dosed simultaneously to the dosage of estrone-sulfate steroid (E1S) in the extract by the separative method coupled to mass spectrometry to determine the concentration in the extract of said testosterone as an additional steroid.

### Claim 9 (depends on 1)

A process according to claim 1 wherein the ungulate is the American Bison (Bison bison bison or Bison bison athabascae).

### Claim 10

A kit for determining pregnancy and/or a pregnancy stage of an ungulate from its feces, comprising:
an extraction buffer for extracting steroids from an ungulate's feces sample,
a reconstitution buffer for reconstituting the extracted steroids in a precise volume of solution compatible with a separative method coupled to mass spectrometry,
a separation means, in particular a chromatographic column, for separating the steroids with the separative method coupled to mass spectrometry,
at least one mobile phase for transporting the extracted steroids through the separation means, in particular through the chromatographic column,
an internal standard mix being a mixture of isotopically labelled compounds, chemically similar to the steroids of interest, said internal standard mix comprising at least estrone-sulfate steroid (E1S) isotopically labelled,
a calibrator solution for calibrating the separative method coupled to mass spectrometry, said calibrator solution comprising estrone-sulfate steroid (E1S).

### Claim 11 (depends on 10)

A kit according to claim 10, further comprising a precolumn.

### Claim 12 (depends on 10)

A kit according to claim 10, further comprising at least one control solution for monitoring the accuracy and precision of the separative method coupled to mass spectrometry.

### Claim 13 (depends on 10)

A kit according to claim 10, wherein the internal standard mix further comprises testosterone isotopically labelled.

### Claim 14 (depends on 10)

A kit according to claim 10, further comprising a rinsing solution for rinsing the separation means and the system used for the separative method coupled to mass spectrometry.
